SCYL2

SCYL2 (CVAK104) is a clathrin-coated vesicle-associated pseudokinase that functions as a sorting and signaling regulator at the clathrin trafficking machinery (PMID:15809293, PMID:16914521). It co-fractionates with clathrin-coated vesicles and binds directly to clathrin (via the N-terminal domain) and the AP2 adaptor (via the alpha-appendage), with membrane association being clathrin-dependent and perinuclear recruitment requiring GTP-binding proteins (PMID:15809293, PMID:16914521). SCYL2 localizes to the trans-Golgi network and endosomal compartments where it associates with clathrin, AP-1, and epsinR, and is required for proper sorting of cargo into clathrin-coated vesicles, including the lysosomal hydrolase cathepsin D and the SNAREs syntaxin 8 and vti1b (PMID:16914521, PMID:17587408). Through this trafficking activity SCYL2 controls the fate of specific receptors: it drives clathrin-mediated lysosomal degradation of Frizzled-5 to act as a negative regulator of Wnt/beta-catenin signaling (PMID:19643732), and in neurons it maintains the composition of excitatory receptors at synapses, with its loss causing BAX-dependent apoptotic degeneration of CA3 hippocampal neurons due to excitotoxicity (PMID:26203146). SCYL2 additionally serves as a scaffold that couples phosphatase activity to its substrates, recruiting PP2A to dephosphorylate HIV-1 Vpu and thereby restrict viral release (PMID:23047923). A clathrin-coated-vesicle SCYL2 complex also promotes phosphorylation of PTEN at the STT cluster, linking SCYL2 to PI3K/AKT signaling (PMID:41703271).

1. 2005 High

   Establishing whether SCYL2 was a bona fide component of the clathrin machinery and an active enzyme determined how to frame its cellular role; the finding placed it at clathrin-coated vesicles with kinase-like activity toward an adaptor subunit.

   Evidence Mass spectrometry, in vitro kinase and ATP-binding assays, and co-fractionation with clathrin-coated vesicle preparations

   PMID:15809293

   Open questions at the time

   • In vitro phosphorylation of beta2-adaptin does not establish a physiological substrate
   • Whether catalytic activity is required for any cellular function was not tested
2. 2006 High

   Defining SCYL2's subcellular localization and the determinants of its membrane recruitment showed it operates in TGN-to-endosome clathrin trafficking rather than only at the plasma membrane.

   Evidence RNAi, live-cell imaging, GTPgammaS/brefeldin A perturbation, cathepsin D sorting assay, and direct binding assays to clathrin N-terminal domain and AP2 alpha-appendage

   PMID:16914521

   Open questions at the time

   • Identity of the GTP-binding protein required for perinuclear recruitment unspecified
   • Mechanism linking SCYL2 loss to cathepsin D missorting not resolved
3. 2007 High

   Identifying a specific cargo class clarified what SCYL2 sorts; it is required for incorporation of selected SNAREs into clathrin-coated vesicles.

   Evidence Reciprocal co-immunoprecipitation, comparative CCV proteomics, siRNA knockdown, and immunofluorescence colocalization

   PMID:17587408

   Open questions at the time

   • Whether SNARE sorting depends on direct SCYL2 binding versus an indirect adaptor effect is unresolved
   • Functional consequence of syntaxin 8/vti1b mislocalization not measured
4. 2009 High

   Connecting SCYL2-dependent trafficking to a signaling output demonstrated it degrades a specific Wnt receptor and thereby tunes pathway activity.

   Evidence Co-IP with Dvl and Fzd5, gain/loss-of-function RNAi, dominant-negative Rab5 epistasis, lysosomal inhibition, and Wnt/beta-catenin reporter assay

   PMID:19643732

   Open questions at the time

   • Basis for Fzd5 selectivity over Fzd1/Fzd4 not defined
   • Role of SCYL2 catalytic activity in Fzd5 degradation untested
5. 2012 High

   Showing SCYL2 recruits a phosphatase to a viral substrate revealed a scaffolding mode distinct from its sorting role and a function in innate antiviral restriction.

   Evidence Co-IP defining a SCYL2-Vpu-PP2A complex, siRNA knockdown, Vpu phospho-site analysis, virion release assay, and interferon induction

   PMID:23047923

   Open questions at the time

   • Whether SCYL2 directly bridges PP2A and Vpu or acts via the trafficking machinery is unclear
   • Generalizability of the PP2A-recruitment scaffold to host substrates not explored
6. 2015 High

   An in vivo genetic test established the physiological importance of SCYL2 in neurons, linking its trafficking role to control of synaptic excitatory receptor composition and survival.

   Evidence Neuron-specific conditional knockout mice with histology, electrophysiology, BAX genetic epistasis, synaptic fractionation, and pharmacological rescue of excitatory signaling

   PMID:26203146

   Open questions at the time

   • Specific receptor subunits trafficked by SCYL2 not molecularly identified
   • Mechanistic link between altered receptor composition and BAX-dependent apoptosis not delineated
7. 2026 Medium

   Implicating a SCYL2-clathrin complex in PTEN phosphorylation extended SCYL2 into PI3K/AKT signaling and a potential tumor context.

   Evidence Co-IP of SCYL2 with PTEN and CHC, siRNA knockdown of SCYL2 and CHC, PTEN STT-cluster phosphorylation assay, and cell survival assay

   PMID:41703271

   Open questions at the time

   • The kinase responsible for and mechanism of PTEN phosphorylation remains unclear per the study itself
   • Whether SCYL2 phosphorylates PTEN directly versus recruiting another kinase is untested
   • Single-lab Co-IP without reciprocal in vivo validation

• Whether SCYL2's catalytic activity is required for its diverse trafficking and signaling functions, and how a single CCV-associated protein selects among such varied substrates (SNAREs, Fzd5, Vpu/PP2A, PTEN), remains unresolved.
• No structural model of SCYL2 substrate or adaptor selectivity
• No catalytically-dead mutant rescue across the reported functions
• Mechanism unifying scaffold versus kinase roles not established